Literature DB >> 9186451

Cardiac disease during pregnancy--a Free State perspective on maternal morbidity and mortality.

M G Schoon1, R H Bam, L Wolmarans.   

Abstract

AIM: Description of maternal outcome of pregnancies complicated by cardiac disease.
SETTING: Pelonomi Hospital, Bloemfontein. POPULATION: Black African women of low socio-economic background who presented with cardiac disease during pregnancy. SAMPLE: All patients who delivered from 1 January 1990 to 1 January 1995.
DESIGN: Descriptive retrospective study.
RESULTS: Cardiac disease complicated 0.6% of pregnancies. Rheumatic valvular disease dominated in this population. The maternal mortality rate was 9.5% while the maternal morbidity rate ranged from 50% to 100% for the various lesions.
CONCLUSIONS: Cardiac disease in pregnancy has high maternal mortality and morbidity rates. Hypertension, anticoagulation therapy, late referrals and inadequate counselling were important contributing factors. A high priority should be given to meticulous contraceptive counselling in patients with cardiac disease. Collaboration between obstetricians, physicians and cardiothoracic surgeons in imperative.

Entities:  

Mesh:

Year:  1997        PMID: 9186451

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

Review 1.  Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Authors:  Vuyisile T Nkomo
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

Review 2.  The burden of antenatal heart disease in South Africa: a systematic review.

Authors:  David A Watkins; Motshedisi Sebitloane; Mark E Engel; Bongani M Mayosi
Journal:  BMC Cardiovasc Disord       Date:  2012-03-30       Impact factor: 2.298

3.  Delivering obstetrical critical care in developing nations.

Authors:  Sukhwinder Kaur Bajwa; Sukhminder Jit Singh Bajwa
Journal:  Int J Crit Illn Inj Sci       Date:  2012-01

Review 4.  Closed Mitral Valvotomy Reenvision.

Authors:  Swati Pathak; Rajeshwar Yadav
Journal:  Cureus       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.